tradingkey.logo

Allurion Technologies Inc

ALUR
1.100USD
+0.030+2.80%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
8.54MCap. mercado
PérdidaP/E TTM

Allurion Technologies Inc

1.100
+0.030+2.80%

Más Datos de Allurion Technologies Inc Compañía

Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.

Información de Allurion Technologies Inc

Símbolo de cotizaciónALUR
Nombre de la empresaAllurion Technologies Inc
Fecha de salida a bolsaMar 29, 2021
Director ejecutivoGaur (Shantanu)
Número de empleados134
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 29
Dirección11 Huron Dr Ste 200
CiudadNATICK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal01760
Teléfono15086474000
Sitio Webhttps://www.allurion.com/en
Símbolo de cotizaciónALUR
Fecha de salida a bolsaMar 29, 2021
Director ejecutivoGaur (Shantanu)

Ejecutivos de Allurion Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-16000.00%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+604.00%
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
62.03K
-16000.00%
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
1.21K
+604.00%
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Dr. Ram Chuttani
Dr. Ram Chuttani
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
All other countries
941.00K
35.40%
Egypt (Country)
450.00K
16.93%
Italy
418.00K
15.73%
Spain
282.00K
10.61%
Argentina
272.00K
10.23%
Otro
295.00K
11.10%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 1 de feb
Actualizado: dom., 1 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
RTW Investments L.P.
47.98%
Leavitt Equity Partners III LP
3.77%
Armistice Capital LLC
1.51%
Lunt Capital Management Inc
1.36%
Romulus Capital Management, LLC
1.33%
Otro
44.06%
Accionistas
Accionistas
Proporción
RTW Investments L.P.
47.98%
Leavitt Equity Partners III LP
3.77%
Armistice Capital LLC
1.51%
Lunt Capital Management Inc
1.36%
Romulus Capital Management, LLC
1.33%
Otro
44.06%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
48.42%
Corporation
4.83%
Investment Advisor
3.06%
Hedge Fund
1.63%
Individual Investor
1.53%
Venture Capital
1.43%
Otro
39.09%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
69
6.70M
54.55%
+3.08M
2025Q3
70
3.18M
46.56%
+1.57K
2025Q2
85
3.18M
48.45%
-269.85K
2025Q1
86
1.95M
28.76%
+237.16K
2024Q4
84
752.22K
40.38%
-48.13K
2024Q3
168
830.35K
127.59%
-73.34K
2024Q2
179
581.38K
156.78%
+113.95K
2024Q1
186
467.42K
172.37%
-2.84M
2023Q4
188
468.03K
181.14%
+55.07K
2023Q3
189
413.41K
181.62%
-47.54K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
RTW Investments L.P.
5.89M
63.6%
+3.35M
+131.71%
Nov 12, 2025
Leavitt Equity Partners III LP
462.76K
5%
+296.10K
+177.66%
Feb 19, 2025
Armistice Capital LLC
185.00K
2%
-206.64K
-52.76%
Jun 30, 2025
Romulus Capital Management, LLC
163.14K
1.76%
--
--
Oct 31, 2025
Compute Health Sponsor LLC
130.51K
1.41%
--
--
Oct 31, 2025
The Vanguard Group, Inc.
56.18K
0.61%
+6.82K
+13.81%
Sep 30, 2025
Gupta (Krishna K.)
76.18K
0.82%
+3.12K
+4.27%
Oct 31, 2025
Gaur (Shantanu)
62.03K
0.67%
-16.00K
-20.50%
Oct 31, 2025
Olayan Investments Company Establishment
49.70K
0.54%
--
--
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
iShares Micro-Cap ETF
Proporción0%
Janus Henderson Small Cap Growth Alpha ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Fecha
Fecha ex-dividendo
Tipo
Relación
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
Dec 24, 2024
Merger
25→1
KeyAI